Rübben H - Search Results

1

[Siliconchiptechnology-based MMP-7 analysis in urine: an option for preoperative identification of lymph node metastasis in bladder cancer].

Jäger T, Tschirdewahn S, Vom Dorp F, Piechotta G, Rübben H, Szarvas T. Jäger T, et al. Among authors: rubben h. Urologe A. 2013 Jun;52(6):853-8. doi: 10.1007/s00120-012-3110-4. Urologe A. 2013. PMID: 23358831 Clinical Trial. German.

2

Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer.

Szarvas T, Jäger T, Becker M, Tschirdewahn S, Niedworok C, Kovalszky I, Rübben H, Ergün S, vom Dorp F. Szarvas T, et al. Among authors: rubben h. Pathol Oncol Res. 2011 Jun;17(2):325-32. doi: 10.1007/s12253-010-9320-4. Epub 2011 Jan 21. Pathol Oncol Res. 2011. PMID: 21253919 Free article.

3

[Upper urinary tract cancer].

Tschirdewahn S, Rübben H. Tschirdewahn S, et al. Among authors: rubben h. Urologe A. 2019 Jan;58(1):3-4. doi: 10.1007/s00120-018-0827-8. Urologe A. 2019. PMID: 30666375 German. No abstract available.

4

[Value of systemic chemotherapy in bladder cancer].

Goebell PJ, vom Dorp F, Rübben H. Goebell PJ, et al. Among authors: rubben h. Urologe A. 2006 May;45(5):586, 588-90, 592-3. doi: 10.1007/s00120-006-1058-y. Urologe A. 2006. PMID: 16710678 Review. German.

5

[Noninvasive and invasive bladder cancer: diagnostics and treatment].

Goebell PJ, Vom Dorp F, Rödel C, Frohneberg D, Thüroff JW, Jocham D, Stief C, Roth S, Knüchel R, Schmidt KW, Kausch I, Zaak D, Wiesner C, Miller K, Sauer R, Rübben H. Goebell PJ, et al. Among authors: rubben h. Urologe A. 2006 Jul;45(7):873-84; quiz 885. doi: 10.1007/s00120-006-1065-z. Urologe A. 2006. PMID: 16791629 Review. German.

6

[Palliative therapy concepts for patients with urothelial cancer of the urinary bladder].

Vom Dorp F, Börgermann C, Rübben H. Vom Dorp F, et al. Among authors: rubben h. Urologe A. 2007 Jan;46(1):54-5. doi: 10.1007/s00120-006-1276-3. Urologe A. 2007. PMID: 17203266 Review. German.

7

[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].

Jäger T, Szarvas T, vom Dorp F, Börgermann C, Schenck M, Schmid KW, Rübben H. Jäger T, et al. Among authors: rubben h. Urologe A. 2007 Sep;46(9):1152-6. doi: 10.1007/s00120-007-1429-z. Urologe A. 2007. PMID: 17593336 German.

8

[Prognostic factors of urinary bladder carcinoma].

vom Dorp F, Jaeger T, Schmidt K, Siffert W, Rübben H. vom Dorp F, et al. Among authors: rubben h. Urologe A. 2007 Sep;46(9):1151. doi: 10.1007/s00120-007-1430-6. Urologe A. 2007. PMID: 17641868 Clinical Trial. German. No abstract available.

9

[Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].

Rossi R, Jaeger T, Börgermann C, Furtkamp C, Moos Stahl R, Rübben H, vom Dorp F. Rossi R, et al. Among authors: rubben h. Urologe A. 2007 Sep;46(9):1145-7. doi: 10.1007/s00120-007-1470-y. Urologe A. 2007. PMID: 17661004 German.

10

[Is there an indication for adjuvant or neoadjuvant systemic therapy in prostate cancer?].

Börgermann C, Miller K, vom Dorp F, Jäger T, Rübben H. Börgermann C, et al. Among authors: rubben h. Urologe A. 2007 Oct;46(10):1385-6, 1388. doi: 10.1007/s00120-007-1544-x. Urologe A. 2007. PMID: 17874231 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters